Long‑Term Durability of Active Surveillance of Small, Low‑Risk Papillary Thyroid Cancer
In this cohort study of patients with small, low‑risk PTC, 118 of 155 patients (76%) who chose AS continued AS in the absence of disease progression or other indications for surgery at long‑term follow‑up (median [IQR] follow‑up duration, 71 [59‑84] months).
Reference provided abstract text was not included in the source_content excerpt; thus abstract_en is set to null.
This study demonstrates that active surveillance (AS) remains a durable management strategy for small, low‑risk papillary thyroid cancer (PTC), particularly in older patients, suggesting that age should be considered when counseling patients about long‑term disease control.
Bizonyítékszint: Korai humán adat. Kis vagy feltáró emberi adat.
Kapcsolódó jelek
- The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma
- The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancer
- Improving predicted risk of recurrence using molecular profiling in papillary thyroid cancer
- Global Burden of Thyroid Cancer in Adults Age 15‑49 Years and Its Predictions: Findings From Global Burden of Disease Study 2021
- Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management